This site is intended for healthcare professionals
News

Global Coalition for Adaptive Research, Amgen, and Eisai announce first patient enrolled in REMAP-COVID trial involving apremilast and eritoran.

Read time: 1 mins
Last updated:29th Oct 2020
Published:28th Oct 2020
Condition: Coronavirus/COVID-19 Infection
Type: drug
Register free for full access to medthority.com